Denmark: Mads Møller Kristensen and DanCann Pharma parting ways

DanCann Pharma, a Danish biopharmaceutical company focussed on the development, manufacturing and commercialising of therapeutic cannabinoids, is parting ways with CFO Mads Møller Kristensen. He has been the CFO of DanCann Pharma since May 2020. Møller Kristensen leaves at the end of May 2022. He will help with the transfer of the tasks, while the company…

You must be a HMI Subscriber to view this content.

Subscribe Now »